CS logo
small CS logo
Providence Regional Cancer System-Centralia

Centralia, Washington, United States
Cancer treatment center in Centralia, Washington
2015 Cooks Hill Rd Suite 200, Centralia, WA 98531

About Providence Regional Cancer System-Centralia


"At Providence, we know how terrifying a cancer diagnosis is. We are here to provide the best possible cancer care, counseling and support for you. Our Cancer Center in Centralia provides you with the regular treatments you need, close to home. You can have appointments with your specialists and get your treatments without the expense, discomfort and stress of traveling out of town. We will help you and your family navigate through your cancer journey with the best medical treatment and support we can offer. We also want to make it convenient, which is why our extensive network of care gives you access to expanded chemotherapy and radiation therapy services right here in Lewis County."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
104
SWOG Cancer Research Network
37
Alliance for Clinical Trials in Oncology
32
ECOG-ACRIN Cancer Research Group
16
Gynecologic Oncology Group
7
GOG Foundation
3
NRG Oncology
3
Children's Oncology Group
2
Wake Forest University Health Sciences
2
ETOP IBCSG Partners Foundation
1
NSABP Foundation Inc
1
Total Rows: 12

Clinical Trials at Providence Regional Cancer System-Centralia


During the past decade, Providence Regional Cancer System-Centralia conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 77 clinical trials were completed, i.e. on average, 63.1% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 45 clinical trials were completed. i.e. 132.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1313161616161919242427277744774455121217171414Started TrialsCompleted Trails20152016201720182019202020210102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
2000-11-20
2016-07-16
Completed
31
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
2002-06-01
2015-10-01
Completed
147
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
2002-09-01
2012-01-01
Completed
76
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
2003-12-01
2009-08-01
Completed
24

Rows per page:

1–100 of 209

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Providence Regional Cancer System-Centralia" #1 sponsor was "National Cancer Institute (NCI)" with 104 trials, followed by "SWOG Cancer Research Network" with 37 trials sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "Gynecologic Oncology Group" with 16 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Regional Cancer System-Centralia" #1 collaborator was "National Cancer Institute (NCI)" with 105 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 6 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 32 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 104National CancerInstitute (NCI): 104SWOG Cancer ResearchNetwork: 37SWOG Cancer ResearchNetwork: 37Alliance for ClinicalTrials in Oncology: 32Alliance for ClinicalTrials in Oncology: 32ECOG-ACRIN CancerResearch Group: 16ECOG-ACRIN CancerResearch Group: 16Gynecologic Oncology Group: 7Gynecologic Oncology Group: 7GOG Foundation: 3GOG Foundation: 3NRG Oncology: 3NRG Oncology: 3Children's Oncology Group: 2Children's Oncology Group: 2Wake Forest UniversityHealth Sciences: 2Wake Forest UniversityHealth Sciences: 2ETOP IBCSG PartnersFoundation: 1ETOP IBCSG PartnersFoundation: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 105National CancerInstitute (NCI): 105NRG Oncology: 18NRG Oncology: 18Canadian Cancer Trials Group: 8Canadian Cancer Trials Group: 8Cancer and LeukemiaGroup B: 7Cancer and LeukemiaGroup B: 7North Central CancerTreatment Group: 6North Central CancerTreatment Group: 6SWOG Cancer ResearchNetwork: 6SWOG Cancer ResearchNetwork: 6NCIC Clinical Trials Group: 5NCIC Clinical Trials Group: 5Genentech, Inc.: 3Genentech, Inc.: 3American College ofSurgeons: 2American College ofSurgeons: 2MillenniumPharmaceuticals, Inc.: 2MillenniumPharmaceuticals, Inc.: 2

Clinical Trials Conditions at Providence Regional Cancer System-Centralia


According to Clinical.Site data, the most researched conditions in "Providence Regional Cancer System-Centralia" are "Invasive Breast Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (8 trials) and "Cervical Adenocarcinoma" (7 trials). Many other conditions were trialed in "Providence Regional Cancer System-Centralia" in a lesser frequency.

Clinical Trials Intervention Types at Providence Regional Cancer System-Centralia


Most popular intervention types in "Providence Regional Cancer System-Centralia" are "Drug" (172 trials), "Other" (127 trials), "Biological" (99 trials), "Procedure" (57 trials) and "Radiation" (30 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "Quality-of-Life Assessment" (56 trials), "Questionnaire Administration" (33 trials), "Computed Tomography" (30 trials) and "Paclitaxel" (30 trials). Other intervention names were less common.

Clinical Trials Genders at Providence Regional Cancer System-Centralia


The vast majority of trials in "Providence Regional Cancer System-Centralia" are 169 trials for "All" genders, 38 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Providence Regional Cancer System-Centralia


Currently, there are NaN active trials in "Providence Regional Cancer System-Centralia". undefined are not yet recruiting, 56 are recruiting, 100 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Providence Regional Cancer System-Centralia, 5 suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Providence Regional Cancer System-Centralia, 5 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 114 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 114Phase 3: 114Phase 2: 100Phase 2: 100Phase 1: 5Phase 1: 5Not Applicable: 3Not Applicable: 3

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 100Active, not recruiting: 100Recruiting: 56Recruiting: 56Completed: 40Completed: 40Terminated: 7Terminated: 7Suspended: 5Suspended: 5Unknown status: 1Unknown status: 1